Prosecution Insights
Last updated: October 25, 2026

Mccarter & English, LLP Boston

Technology area: Biotechnology & Pharmaceuticals

314 pending office actions • 132 clients • 283 examiners • 161 art units • 0 of 314 (0%) have an AI response strategy ready • 384 patents granted in the last 365 days

Analysis

This profile covers Biotechnology & Pharmaceuticals and includes 9201 career applications. Its resolved allowance rate is 82.16%, and the average is 3.54 office actions per allowance. The data reflects a substantial prosecution record with a reported allowance outcome for a majority of resolved matters and repeated office-action activity before allowance.

The profile shows 312 pending office actions, creating a large active docket. That workload makes prioritization, response coordination, and consistent treatment of recurring examination issues practical necessities. The historical allowance rate and action average can guide portfolio planning, but they do not determine the result of any pending application. Counsel should use the metrics as context while evaluating each biotechnology and pharmaceutical case on its own record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=9201 apps, methodology: how we score firms)

82.2%
Allowance Rate
n=9201
+0.71σ
Allowance Rate (norm)
n=9201
3.5
OAs to Allowance
n=4800
-0.16σ
OAs to Allow (norm)
n=4800
1088 days
Time to Allowance
n=4800
+16.8pp
Interview Lift
n=9201
32.0%
RCE Rate
n=9201
0.9%
Appeal Rate
n=9201

Rejection Performance (% of received rejections ultimately overcome)

73.6%
§101 Overcome
n=658
73.4%
§102 Overcome
n=2031
74.4%
§103 Overcome
n=3345
77.1%
§112 Overcome
n=3003

Specialization & Scale

A61K, A61P, C07D
Top CPC Subclasses
29%
Top-3 CPC Share
n=9201
0
Practitioners
n=9201
—
Apps / Practitioner
n=9201 (min 20)

Portfolio Summary

314
Total Pending OAs
198
Non-Final OAs
107
Final Rejections
9
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 94 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

42
Overdue
5
Due this week
23
Due this month
10
Due in next 60 days
14
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 94 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (42)Due ≤ 7 days (5)Due ≤ 30 days (23)Due ≤ 60 days (10)Due later (14)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

146
Hard (46%)
119
Medium (38%)
44
Easy (14%)
5
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only5 (2%)
§101 + other29 (9%)
§103 only69 (22%)
§102 only16 (5%)
§112 only33 (11%)
Double-patenting only11 (4%)
Double-patenting + other34 (11%)
Multi-statute (no §101)112 (36%)
No statute on record5 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

164
Life Sciences
52% of docket
12
Information Tech
4% of docket
17
Communications
5% of docket
29
Semiconductors
9% of docket
90
Mechanical / Eng
29% of docket
2
Business / Other
1% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

3,140 h
Manual time on pending OAs
628 h
Time saved (low, 20%)
1,099 h
Time saved (mid, 35%)
27.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HERNANDEZ, JACKSON J 5 50.7% +39.2%
BEGEMAN, ANDREW W 4 47.1% +19.0%
TEHRANI, DANIEL 3 60.9% +41.9%
WILLIS, DOUGLAS M 3 82.4% +19.7%
GRANT, ROBERT J 3 76.3% +17.5%
CHEN, WENREN 2 15.3% +29.2%
VARMA, ASHISH K 2 74.4% +32.4%
ANDERSON, REBECCA L 2 73.3% +23.7%
REDWOOD, CHRISTOPHER EVAN 2 0.0% +0.0%
RATCLIFFE, LUKE D 2 87.2% +10.4%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18945261 VEHICLE WITH A GATED CAMERA AND METHOD FOR OPERATING A VEHICLE UTILIZING A GATED CAMERA RATCLIFFE, LUKE D —
18798308 INHIBITORS OF BTK AND MUTANTS THEREOF WILLIS, DOUGLAS M —
18514898 METHOD OF OPERATING A COORDINATE MEASUREMENT DEVICE RATCLIFFE, LUKE D —

Hard Cases (147)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18625848 ADAPTIVE CONTROL OF LIGHTING THAT UTILIZES REMOVABLE DIFFUSERS CHAI, RAYMOND REI-YANG 188d overdue
18030633 VACCINE COMPOSITIONS GILL, RACHEL B 118d overdue
18045476 FOLDIBLE REACHING AND GRASPING TOOL LEEDS, DANIEL JEREMY 89d overdue
17429451 PROSTHETIC TOOTH NELSON, CHRISTINE L 80d overdue
18554778 2-((4-((S)-2-(4-CHLORO-2-FLUOROPHENYL)-2-METHYLBENZO[D][1,3]DIOXOL-4-YL)PIPERIDIN-1-YL)METHYL)-1-(((S)-OXETAN-2-YL)METHYL)-1H-IMIDAZOLE DERIVATIVES AS ACTIVATORS OF THE GLP1 RECEPTOR FOR THE TREATMENT OF OBESITY BORALSKY, LUKE ALAN 53d overdue
18047255 TREATMENT OF RPE65-ASSOCIATED EYE DISEASES AND DISORDERS SINGH, ANOOP KUMAR 42d overdue
18128937 ALTERNATING ELECTRIC FIELD WAVEFORM FOR ELECTROSENSATION REDUCTION SIRCAR, ALISHA JITENDRA 32d overdue
18412266 ADAPTIVE CONTROL OF DOMAIN NAME REGISTRATIONS VIA DYNAMICALLY VARIABLE REGISTRATION REQUIREMENTS SEIBERT, CHRISTOPHER B 30d overdue

Interview Candidates (26)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16938515 Devices and Methods for Ultrasound Monitoring BEGEMAN, ANDREW W 37d overdue
18196379 TRANSCRANIAL ULTRASOUND DEVICES AND METHODS BEGEMAN, ANDREW W 7d
17698457 TRANSDUCER APPARATUSES FOR DELIVERING TUMOR TREATING FIELDS TO A SUBJECT'S BODY TEHRANI, DANIEL 7d
18080026 TRANSDUCER ARRAY WITH ADHESIVE LAYER SHAPED TO REDUCE SKIN IRRITATION TEHRANI, DANIEL 9d
18023035 1H-IMIDAZO [4,5-H] QUINAZOLINE COMPOUND AS NOVEL SELECTIVE FLT3 INHIBITORS HERNANDEZ, JACKSON J 15d
17640704 CANCER IMMUNOTHERAPY HERNANDEZ, JACKSON J 30d
18090316 DEVICES AND METHODS FOR ULTRASOUND MONITORING BEGEMAN, ANDREW W 60d
18283301 A DEVICE, A METHOD AND A SOFTWARE PRODUCT FOR ADAPTING A REGULATED DIGITAL PLATFORM CHEN, WENREN 76d

Client Portfolio (132 clients)

View all 132 →

Top Art Units

Art UnitApps
16249
16268
37928
16217
16277
16456
16296
16226
28596
36455

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19019869 Untitled General Electric Company CHEN, WENREN 3626 §101§103§112 Final Rejection — Pending
19541682 CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING LOW-DENSITY LIPOPROTEIN RECEPTOR (LDLR) Editas Medicine, Inc. MEAH, MOHAMMAD Y 1652 §103§112 Non-Final OA — Pending Feb 17, 2026
19425122 SYSTEM AND METHOD FOR DILUTING SUBSEA SCALING INHIBITOR TO PREVENT PRODUCTION STRING BREAKDOWN Petróleo Brasileiro S.A. - Petrobras QUAIM, LAMIA 3676 §102§112 Non-Final OA — Pending Dec 18, 2025
19389508 System for Preventive Inhibition of Scaling in Oil Wells and Process for Preventive Inhibition of Scaling in Oil Wells Petróleo Brasileiro S.A. - Petrobras VARMA, ASHISH K 3674 §103§112 Non-Final OA — Pending Nov 14, 2025
19372624 SYSTEM AND METHOD FOR BLADE PITCH CONTROL OF CYCLOIDAL MARINE PROPULSION SYSTEM ABB Schweiz AG ZAMORA ALVAREZ, ERIC J 3745 §102§103 Non-Final OA — Pending Oct 29, 2025
19367242 VACUUM SEALABLE CONTAINER Honeybee Robotics, LLC CASTELLANO, STEPHEN J 3733 §103§112 Non-Final OA — Pending Oct 23, 2025
19273187 IMMERSED ROTARY JET SPINNING DEVICES (IRJS) AND USES THEREOF President and Fellows of Harvard College LEYSON, JOSEPH S 1744 §112DP Non-Final OA — Pending Jul 18, 2025
19234885 LIGHT ASSEMBLY CONTROLLER VIDENDUM PRODUCTION SOLUTIONS INC. CHAN, WEI 2845 §103 Non-Final OA — Pending Jun 11, 2025
19137229 SYSTEMS AND METHODS FOR AIRCRAFT PROPULSION Limo Air Drive Corp. GENTILE, ALEXANDER VINCENT 3664 §102§103 Non-Final OA — Pending Jun 09, 2025
19135524 METHOD OF CONTROLLING A MINING VEHICLE AND SCHEDULING SYSTEM FOR GENERATING A DRIVING SCHEDULE FOR A MINING VEHICLE ABB Schweiz AG SARWAR, BABAR 3667 §101§103DP Non-Final OA — Pending Jun 04, 2025
19134828 METHODS OF MODULATING IMMUNE FUNCTION IN PLANTS Resurrect Bio Ltd. FAN, WEIHUA 1663 §102§103§112 Non-Final OA — Pending Jun 02, 2025
19178563 Device and Method for Disconnecting Jammed Subsea Wet-Mate Connectors Petróleo Brasileiro S.A. - Petrobras SAYRE, JAMES G 3679 §102 Final Rejection 53d overdue Pending Apr 14, 2025
19094272 PAYLOAD RELEASE SYSTEM Ensign-Bickford Aerospace & Defense Company RODRIGUEZ, VICENTE M 3642 §102§103 Final Rejection 33d Pending Mar 28, 2025
19094375 SYSTEMS AND METHODS FOR BEHAVIOR ADAPTATION OF AUTOMATED DRIVING SYSTEMS BASED ON DRIVING STYLES OF SURROUNDING ROAD ACTORS Torc Robotics, Inc. AWORUNSE, OLUWABUSAYO ADEBANJO 3662 §103§112 Final Rejection — Pending Mar 28, 2025
19113882 ACTIVE FILTER PRE-CHARGING FOR A CONVERTER WITH ACTIVE FILTER CELLS ABB Schweiz AG TIKU, SISAY G 2838 §112 Non-Final OA — Pending Mar 20, 2025
19085483 AUTONOMOUS VEHICLE LEAK DETECTION Torc Robotics, Inc. LEE, BRANDON DONGPA 3662 §101§103§112 Non-Final OA — Pending Mar 20, 2025
19082476 RECOMBINANT ATTENUATED SALMONELLA VACCINES (RASVS) AGAINST INFECTIONS BY AVIAN PATHOGENIC ESCHERICHIA COLI (APEC) Huvepharma Inc. HAUK TEODORO, PRICILA NMN 1645 §103 Non-Final OA — Pending Mar 18, 2025
19075625 INTEGRATED DNS SERVICE PROVIDER SERVICES USING CERTIFICATE-BASED AUTHENTICATION Verisign, Inc. AHSAN, SYED M 2491 §112 Non-Final OA — Pending Mar 10, 2025
19069470 SUSTAINABLE MOVEMENT PLANNING FOR AN ELECTROMAGNETIC TRANSPORT SYSTEM ABB Schweiz AG SLOWIK, ELIZABETH J 3662 §103 Non-Final OA — Pending Mar 04, 2025
19059891 GTLD DOMAIN NAME REGISTRIES RDAP ARCHITECTURE Verisign, Inc. RASHID, HARUNUR 2497 §112 Non-Final OA — Pending Feb 21, 2025
19105140 DIETARY SUPPLEMENTS COMPRISING SILICA PARTICLES Sigrid Therapeutics AB GEMBEH, SHIRLEY V 1615 §102§103DP Non-Final OA — Pending Feb 20, 2025
19046780 EXTENDABLE POLE FOR CLEANING TOOL UNGER MARKETING INTERNATIONAL, LLC MAH, CHUCK Y 3677 §103 Final Rejection — Pending Feb 06, 2025
19042947 GATED CAMERA AND GATE-BASED FOCUS ADAPTION Torc Robotics, Inc. CHEN, CHIA WEI A 2637 §103 Final Rejection — Pending Jan 31, 2025
19042136 CYCLONIC SEPARATOR FOR GAS TURBINE ENGINE General Electric Company CLARK, RYAN C 3745 §103 Final Rejection — Pending Jan 31, 2025
19039451 SYSTEMS AND METHODS FOR DYNAMIC SIGNAL SYSTEMS Torc Robotics, Inc. PENDLETON, DIONNE 2689 §103 Final Rejection — Pending Jan 28, 2025
18881934 MODEL PREDICTIVE CONTROL FOR CONVERTER WITH FILTER CELLS BASED ON OFFLINE-COMPUTED PULSE PATTERNS AND ONLINE CELL BALANCING ABB Schweiz AG CHOI, SEUNG HO 2838 §101§103 Non-Final OA — Pending Jan 07, 2025
19004916 SYSTEM AND METHOD FOR ESTIMATING COMPONENT LIFETIME Torc Robotics, Inc. BERNS, MICHAEL ANDREW 3667 §103 Final Rejection — Pending Dec 30, 2024
19004848 SYSTEMS AND METHODS FOR ACTIVE FATIGUE ACCUMULATION MODEL Torc Robotics, Inc. RHEE, ROY B 3664 §102§103 Non-Final OA — Pending Dec 30, 2024
18877741 SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD Teikyo University WRIGHT, ANDREW RUSSELL 2872 §102§103§112 Non-Final OA — Pending Dec 20, 2024
18987624 SYNTHESIS OF BROMODOMAIN INHIBITORS Constellation Pharmaceuticals, Inc. CHEN, PO-CHIH 1621 §102 Non-Final OA — Pending Dec 19, 2024
18986886 LINEAR MOTOR WITH CAPACITIVE POWER TRANSFER B&R Industrial Automation GmbH SECK, AHMED F 2834 §102§103§112 Non-Final OA — Pending Dec 19, 2024
18985488 METHOD FOR OPERATING A LINEAR MOTOR B&R Industrial Automation GmbH IMTIAZ, ZOHEB S 2837 §103 Non-Final OA — Pending Dec 18, 2024
18982504 GATE DRIVE CIRCUIT AND METHOD FOR SWITCHING A SEMICONDUCTOR SWITCH B & R Industrial Automation GmbH BERHANE, ADOLF D 2838 §102 Non-Final OA — Pending Dec 16, 2024
18981748 SHARED REGISTRATION SYSTEM Verisign, Inc. KELLER, MICHAEL A 2418 §112 Non-Final OA — Pending Dec 16, 2024
18874981 CSF-1R INHIBITORS AND USES THEREOF Myrobalan Therapeutics, Inc. ANDERSON, REBECCA L 1626 §112 Non-Final OA — Pending Dec 13, 2024
18981334 MESSAGE AND WARNING DISPLAY SYSTEM FOR A VEHICLE Torc Robotics, Inc. LAU, HOI CHING 2689 §102§103 Non-Final OA — Pending Dec 13, 2024
18980111 PICK AND PLACE SYSTEM FOR LOGISTICS APPLICATIONS B&R Industrial Automation GmbH MARU, TEMESGEN MALLEDE 3651 §103§112 Non-Final OA — Pending Dec 13, 2024
18980787 METHOD FOR DETERMINING A VESSEL WATER INTERFACE, AND METHOD AND SYSTEM FOR DETERMINING A POSITIONAL RELATIONSHIP BETWEEN AN EGO VESSEL AND A TARGET VESSEL ABB Schweiz AG LI, RUIPING 2676 §103 Non-Final OA — Pending Dec 13, 2024
18978367 SYSTEM AND METHOD FOR VEHICLE ALERTING Torc Robotics, Inc. CARDIMINO, CHRISTOPHER RYAN 3661 §103 Final Rejection — Pending Dec 12, 2024
18976553 METHOD FOR LABELLING A WATER SURFACE WITHIN AN IMAGE, METHOD FOR PROVIDING A TRAINING DATASET FOR TRAINING, VALIDATING, AND/OR TESTING A MACHINE LEARNING ALGORITHM, MACHINE LEARNING ALGORITHM FOR DETECTING A WATER SURFACE IN AN IMAGE, AND WATER SURFACE DETECTION SYSTEM ABB Schweiz AG BOYAR, NOAH WILLIAM 2669 §101§102§103 Non-Final OA — Pending Dec 11, 2024
18873192 DIASTOLIC FUNCTION EVALUATION SYSTEM AND ASSOCIATED METHODS Adventist Health System/Sunbelt, Inc. JACOB, OOMMEN 3797 §101§103 Final Rejection — Pending Dec 09, 2024
18872994 METHODS FOR UNIFIED CONCENTRATION AND BUFFER EXCHANGE AstraZeneca AB KRUSE, DAVID H 1663 §103 Non-Final OA — Pending Dec 09, 2024
18971399 METHOD FOR SELECTIVE REMOVAL OF UNDIFFERENTIATED PLURIPOTENT STEM CELLS Buddhist Tzu Chi Medical Foundation MCCORMICK, CATHERINE LYNN 1638 §102§103 Non-Final OA — Pending Dec 06, 2024
18971214 CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES Newave Pharmaceutical Inc. STOCKTON, LAURA LYNNE 1626 §112 Non-Final OA — Pending Dec 06, 2024
18966518 POWER CONVERTER TOPOLOGY AND CONTROL SCHEME FOR MITIGATING THERMAL BOWING IN GAS TURBINE ENGINES General Electric Company CHAU, ALAIN 3741 §102§103§112 Non-Final OA — Pending Dec 03, 2024
18961722 BI-DIRECTIONAL ROBOTIC CRAWLER FOR TRANSPORTING A SENSOR SYSTEM ABOUT A STRUCTURE Honeybee Robotics, LLC FIX, THOMAS S 3618 §102§112 Non-Final OA 77d Pending Nov 27, 2024
18869604 TOUGH ADHESION WITH A TOUGH GEL AND CHITOSAN BRIDGING POLYMER President and Fellows of Harvard College HOLLOMAN, NANNETTE 1612 §103 Non-Final OA — Pending Nov 26, 2024
18960626 DETERMINING TRANSDUCER LOCATIONS FOR DELIVERY OF TUMOR TREATING FIELDS USING SIMULATIONS BASED ON APPROXIMATE TUMOR LOCATION Novocure GmbH SOHRABY, PARDIS 2664 §103 Non-Final OA — Pending Nov 26, 2024
18961009 DETERMINING TRANSDUCER LOCATIONS FOR DELIVERY OF TUMOR TREATING FIELDS USING SIMULATIONS BASED ON MODELS OF HEALTHY SUBJECTS Novocure GmbH BUDISALICH, ANDREW STEVEN 2662 §101§103§112 Non-Final OA — Pending Nov 26, 2024
18958141 AUTOMATIC ANCHOR IMAGE SELECTION Novocure GmbH AMIN, JWALANT B 2612 §103 Non-Final OA — Pending Nov 25, 2024

View all 314 →

Managing Mccarter & English, LLP Boston's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Mccarter & English, LLP Boston's patent allowance rate?

82.2% of resolved applications prosecuted by Mccarter & English, LLP Boston were allowed, across 9,201 applications in USPTO records.

How many office actions does Mccarter & English, LLP Boston average before allowance?

3.54 office actions per allowed application on average.

How many pending office actions does Mccarter & English, LLP Boston have?

314 pending office actions as of October 2026, for 132 clients, before 283 examiners in 161 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month